 |
|
|
| |
Safety and Efficacy of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B
|
| |
| |
Reported by Jules Levin
EASL 2012
Robert Perrillo1, Maria Buti Ferret2, Francois Durand3, Michael Charlton4, Adrian Gadano5, Guido Cantisani6, Kimberly Brown7, Wenhua Hu7, Juan Carlos Lopez-Talavera7, Cyril Llamoso7
1Hepatology Division, Baylor University Medical Center, Dallas, TX, USA; 2. Liver Unit, Hospital General Universitario Vall d'Hebron and Ciberehd del Instituto Carlos III Barcelona, Spain; 3. Service d'Hepatologie, INSERM CRB3, University of Paris VII, Hopital, Beaujon, Clichy 92 110, France; 4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; 5. Sección Hepatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 6. Liver Transplantation Group, Complexo Hospitalar Santa Casa, Porto Alegre-RS, Brazil; Department of Surgery, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre-RS, Brazil; 7. Research and Development, Bristol-Myers Squibb Company, Wallingford, CT, USA
|
| |
|
|
|
|
|
